Nkgomeleng Lekodeba to Cost-Benefit Analysis
This is a "connection" page, showing publications Nkgomeleng Lekodeba has written about Cost-Benefit Analysis.
Connection Strength
0,718
-
Integrated multi-month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost-effectiveness. J Int AIDS Soc. 2025 Feb; 28(2):e26413.
Score: 0,212
-
Cost-effectiveness of SARS-CoV-2 self-testing at routine gatherings to minimize community-level infections in lower-middle income countries: A mathematical modeling study. PLoS One. 2024; 19(10):e0311198.
Score: 0,208
-
Letter to the Editor: "Cost-effectiveness and budget impact analysis of the implementation of differentiated service delivery models for HIV treatment in Mozambique: a modelling study": Resource reductions are not equal to cost savings. J Int AIDS Soc. 2024 Oct; 27(10):e26367.
Score: 0,208
-
Impact and cost-effectiveness of SARS-CoV-2 self-testing strategies in schools: a multicountry modelling analysis. BMJ Open. 2024 Feb 27; 14(2):e078674.
Score: 0,050
-
Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients. J Int AIDS Soc. 2021 04; 24(4):e25692.
Score: 0,041